Table 1.
Demographic and Baseline Characteristics.
| Parameter | Placebo 2 Doses | AERAS-402 (3 x 1010 vp) 2 Doses | Total |
|---|---|---|---|
| (n=4) | (n=8) | (n=12) | |
| Age (years) | |||
| n | 4 | 8 | 12 |
| Mean | 28.3 | 27.4 | 27.7 |
| Age Group (years), n (%) | |||
| 18-30 | 4 (100.0) | 7 (87.5) | 11 (91.7) |
| 31-40 | 0 (0.0) | 1 (12.5) | 1 (8.3) |
| Gender, n (%) | |||
| Male | 4 (100.0) | 8 (100.0) | 12 (100.0) |
| Race, n (%) | |||
| Indian | 4 (100.0) | 8 (100.0) | 12 (100.0) |
| Height (cm) | |||
| n | 4 | 8 | 12 |
| Mean | 164.80 | 168.55 | 167.30 |
| Weight (kg) | |||
| n | 4 | 8 | 12 |
| Mean | 62.28 | 69.50 | 67.09 |
| Body Mass Index (kg/m2) | |||
| n | 4 | 8 | 12 |
| Mean | 22.97 | 24.47 | 23.97 |
| Documentation of BCG Vaccination, n (%) | |||
| Medical history | 4 (100.0) | 8 (100.0) | 12 (100.0) |
| Presence of scar | 4 (100.0) | 8 (100.0) | 12 (100.0) |